CRISPR Therapeutics drives gene-based medicine for severe human illnesses. With it’s efficient CRISPR/Cas9 platform, CRISPR Therapeutics target hemoglobinopathies, cancer, diabetes, and more. CRISPR Therapeutics’ elite team rapidly translates technology into transformative therapies across hemoglobinopathies, immuno-oncology, regenerative medicine, and in vivo applications.
